Enhancement of oral bioavailability of tripterine through lipid nanospheres: Preparation, characterization, and absorption evaluation

Journal of Pharmaceutical Sciences

Volumn 103, Issue 6, 2014, Pages 1711-1719

  Zhang, Xingwang ^a   Zhang, Tianpeng ^a   Zhou, Xiaotong ^a   Liu, Hongming ^a   Sun, Hua ^a   Ma, Zhiguo ^a   Wu, Baojian ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

absorption potential; bioavailability; lipids; nanospheres; oral drug delivery; permeability; tripterine

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; LIPID NANOSPHERE; NANOSPHERE; OLEATE SODIUM; PHOSPHATIDYLCHOLINE; SOYBEAN OIL; TRIPTERINE; UNCLASSIFIED DRUG; WATER; LIPID; NANOPARTICLE; TRITERPENE;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE PERFUSION; PARTICLE SIZE; BIOAVAILABILITY; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIPIDS; NANOPARTICLES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRITERPENES;

EID: 84901272511     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23967     Document Type: Article

References (32)

1. Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S,. 2011. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm 420 (1): 1-10.
2. Li F, Maag H, Alfredson T,. 2008. Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting. J Pharm Sci 97 (3): 1109-1134.
3. Kraft KS, Grant M,. 2009. Preparation of macromolecule-containing dry powders for pulmonary delivery. Methods Mol Biol 480: 165-174.
4. Soliman SM, Abdel Malak NS, El-Gazayerly ON, Abdel Rehim AA,. 2010. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther 4 (6): 459-471.
5. Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, Feng SS,. 2012. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Del Rev 65 (6): 880-890.
6. Chen Y, Lu Y, Chen J, Lai J, Sun J, Hu F, Wu W,. 2009. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 376 (1-2): 153-160.
7. Dahmani FZ, Yang H, Zhou J, Yao J, Zhang T, Zhang Q,. 2012. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: Preparation, in vitro and in vivo evaluation. Eur J Pharm Sci 47 (1): 179-189.
8. Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD,. 2009. Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation. J Control Release 140 (2): 86-94.
9. Zhang ZW, Gao F, Bu HH, Xiao JS, Li YP,. 2012. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: In vitro characteristics and absorption mechanism in rats. Nanomedicine 8 (5): 740-747.
10. Shangguan M, Lu Y, Qi J, Han J, Tian Z, Xie Y, Hu F, Yuan H, Wu W,. 2013. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin. J Biomater Appl 28 (6): 887-896.
11. Porter CJH, Trevaskis NL, Charman WN,. 2007. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6 (3): 231-248.
12. Yu X, Tao W, Jiang F, Li C, Lin J, Liu C,. 2010. Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1. Am J Hypertens 23 (8): 895-903.
13. Wong KF, Yuan Y, Luk JM,. 2012. Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. Clin Exp Pharmacol Physiol 39 (3): 311-320.
14. Liu Z, Ma L, Zhou GB,. 2011. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules 16 (6): 5283-5297.
15. Huang YL, Zhou D, Hang TJ, Wu ZH, Liu JG, Xu QA, Xie XS, Zuo JL, Wang Z, Zhou YX,. 2012. Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol. Anti-Cancer Drugs 23 (5): 515-524.
16. Chen Y, Yuan L, Zhou L, Zhang ZH, Cao W, Wu QQ,. 2012. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine. Int J Nanomed 7: 4581-4591.
17. Doktorovova S, Souto EB,. 2009. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review. Expert Opin Drug Del 6 (2): 165-176.
18. Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J,. 2012. Nanostructured lipid carriers system: Recent advances in drug delivery. J Drug Target 20 (10): 813-830.
19. Dahan A, Hoffman A,. 2006. Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: Correlation with in vivo data and the relationship to intra-enterocyte processes in rats. Pharm Res 23 (9): 2165-2174.
20. Hu S, Niu M, Hu F, Lu Y, Qi J, Yin Z, Wu W,. 2013. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Int J Pharm 441 (1-2): 693-700.
21. Li H, Huo M, Zhou J, Dai Y, Deng Y, Shi X, Masoud J,. 2010. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system. J Pharm Sci 99 (11): 4543-4553.
22. Salminen A, Lehtonen M, Paimela T, Kaarniranta K,. 2010. Celastrol: Molecular targets of Thunder God Vine. Biochem Biophys Res Commun 394 (3): 439-442.
23. Emo M, Stebe MJ, Blin JL, Pasc A,. 2013. Metastable micelles and true liquid crystal behaviour of newly designed "cataniomeric" surfactants. Soft Matter 9 (9): 2760-2768.
24. Pleiss J, Fischer M, Schmid RD,. 1998. Anatomy of lipase binding sites: The scissile fatty acid binding site. Chem Phys Lipids 93 (1-2): 67-80.
25. Zhang J, Li CY, Xu MJ, Wu T, Chu JH, Liu SJ, Ju WZ,. 2012. Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats. J Ethnopharmacol 144 (1): 195-200.
26. Zhou L, Chen Y, Zhang ZH, He JJ, Du M, Wu QQ,. 2012. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine. Pharmazie 67 (4): 304-310.
27. Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP,. 2009. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine 5 (2): 184-191.
28. Park K., 2013. Transport of nanostructured lipid carriers across the intestinal barrier. J Control Release 166 (2): 195-195.
29. Rabanel JM, Aoun V, Elkin I, Mokhtar M, Hildgen P,. 2012. Drug-loaded nanocarriers: Passive targeting and crossing of biological barriers. Curr Med Chem 19 (19): 3070-3102.
30. Siddiqi S, Sheth A, Patel F, Barnes M, Mansbach CM,. 2013. Intestinal caveolin-1 is important for dietary fatty acid absorption. Biochim Biophys Acta 1831 (8): 1311-1321.
31. Yanez JA, Wang SW, Knemeyer IW, Wirth MA, Alton KB,. 2011. Intestinal lymphatic transport for drug delivery. Adv Drug Del Rev 63 (10-11): 923-942.
32. Dahan A, Hoffman A,. 2005. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci 24 (4): 381-388.